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Abstract
Background: Epilepsy is a prevalent neurological disorder worldwide. It is characterized by an enduring predisposition
to generate seizures and its development is accompanied by alterations in many cellular processes. Organotypic slice
cultures represent a multicellular environment with the potential to assess biological mechanisms, and they are used as
a starting point for refining molecules for in vivo studies. Here, we investigated organotypic slice cultures as a model of
epilepsy.
Methods: We assessed, by electrophysiological recordings, the spontaneous activity of organotypic slices maintained
under different culture protocols. Moreover, we evaluated, through molecular-based approaches, neurogenesis,
neuronal death, gliosis, expression of proinflammatory cytokines, and activation of NLRP3 inflammasome
(nucleotide-binding, leucine-rich repeat, pyrin domain) as biomarkers of neuroinflammation.
Results: We demonstrated that organotypic slices, maintained under a serum deprivation culture protocol,
develop epileptic-like activity. Furthermore, throughout a comparative study with slices that do not depict
any epileptiform activity, slices with epileptiform activity were found to display significant differences in
terms of inflammation-related features, such as (1) increased neuronal death, with higher incidence in CA1
pyramidal neurons of the hippocampus; (2) activation of astrocytes and microglia, assessed through western
blot and immunohistochemistry; (3) upregulation of proinflammatory cytokines, specifically interleukin-1β
(IL-1β), interleukin-6, and tumor necrosis factor α, revealed by qPCR; and (4) enhanced expression of NLRP3,
assessed by western blot, together with increased NLRP3 activation, showed by IL-1β quantification.
Conclusions: Thus, organotypic slice cultures gradually deprived of serum mimic the epileptic-like activity,
as well as the inflammatory events associated with in vivo epilepsy. This system can be considered a new
tool to explore the interplay between neuroinflammation and epilepsy and to screen potential drug
candidates, within the inflammatory cascades, to reduce/halt epileptogenesis.
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Background
Epilepsy is among the most prevalent neurological disor-
ders worldwide. According to World Health Organization,
epilepsy accounts for 1% of global burden of disease [1].
Clinically, epilepsy is characterized by recurrent spon-
taneous seizures and is defined, by the International
League Against Epilepsy (ILAE), as “a chronic condition
of the brain characterized by an enduring propensity to
generate epileptic seizures, and by the neurobiological,
cognitive, psychological, and social consequences” [2].
Despite the numerous antiepileptic drugs (AEDs) avail-
able, 30% of patients are still refractory to therapy, con-
tinue to experience seizures, and a subset suffer
progression of the disease, with increasing seizure fre-
quency and cognitive decline. It is therefore imperative
to better understand the mechanisms of epileptogenesis,
the process by which a normal brain transforms into one
* Correspondence: cvalentecastro@medicina.ulisboa.pt
†Daniela M. Magalhães and Noémia Pereira contributed equally to this work.
1Instituto de Farmacologia e Neurociências, Faculdade de Medicina,
Universidade de Lisboa, Lisboa, Portugal
2Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de
Lisboa, Lisboa, Portugal
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Magalhães et al. Journal of Neuroinflammation  (2018) 15:203 
https://doi.org/10.1186/s12974-018-1225-2
capable of producing recurrent spontaneous seizures,
and to find novel and specific therapies to prevent/delay
the onset of this disorder, as well as to ameliorate its
symptoms, and ultimately to cease its progression.
Epileptogenesis is accompanied by several cellular and
molecular processes, such as neuronal death, neurogen-
esis, reactive astrogliosis and microglia activation, and
upregulation of inflammatory mediators [3].
The effect of seizures on neuronal death and the role
of seizure-induced neuronal death in epileptogenesis
have been intensely discussed [4]. αII-Spectrin, a struc-
tural protein of the cell cytoskeleton with a molecular
weight of 250 kDa, is a major substrate of cytosolic cyst-
eine proteases, such as calpains and caspases [5]. Cal-
pains are the main proteases involved in necrosis, while
the effector caspase-3 is considered essential for efficient
execution of apoptosis [6, 7]. Neuronal death leads to ac-
tivation of these cysteine proteases, αII-spectrin cleav-
age, and formation of spectrin breakdown products
(SBDP). Since αII-spectrin occurrence in glial cells is
minimal, SBDPs are considered highly specific for neur-
onal damaged, as well as biomarkers of cell death in
brain disorders [8, 9].
Prolonged seizure activity leads to a dramatic increase
in cell proliferation in the dentate gyrus (DG) [10, 11]
and rostral subventricular zone [12]. In the DG, the ac-
celerated neural stem cell proliferation is reflected by an
increased number of cells expressing doublecortin
(DCX) [11], a validated marker for newborn neurons
[13]. However, the role of new neurons, and their migra-
tion, in the epileptic process is still under debate [14].
Non-neuronal cells, especially astrocytes and micro-
glia, play a prominent role in the pathophysiology of epi-
lepsy [15]. Astrocytes are the third element of the
tripartite synapse [16–18] and active players in neuroin-
flammation [19]. They respond to CNS insults by a
process commonly referred to as reactive astrogliosis, a
graded continuum of progressive alterations [20, 21].
Microglia cells are the main sensors for pathological
events in the CNS, and evidence indicates that the un-
regulated activation of microglia in response to noxious
stimulus results in the production of toxic factors that
propagate neuronal injury [22, 23]. Moreover, as hap-
pens with astrocytes, microglia activation occurs as a
graded response with microglia adopting different
morphologies, ranging from a highly ramified to an
amoeboid-like phenotype [24–26].
Experimental and clinical evidences have also demon-
strated that seizures induce high levels of inflammatory
mediators in brain regions involved in the generation
and propagation of epileptic activity and proinflamma-
tory cytokines, such as interleukin-1β (IL-1β), tumor ne-
crosis factor-α (TNF-α), and interleukin-6 (IL-6), which
were found to be upregulated in activated microglia and
astrocytes [27]. Recently, NOD-like receptor protein 3
(NLRP3) inflammasome has been associated to central
nervous system (CNS)-related disorders [28–30]. NLRP3
is a cytosolic multiprotein complex that assembles in
response to invading pathogens (PAMPs,
pathogen-associated molecular patterns) and danger sig-
nals (DAMPs, damaged-associated molecular patterns),
which results in the processing of inactive pro-caspase-1
into the active cysteine-protease enzyme caspase-1, that
subsequently processes the pro-IL-1β and pro-IL-18,
prompting the production of mature IL-1β and IL-18
and inducing pyroptosis, a highly pyrogenic inflamma-
tory form of cell death. Research suggests that
NLRP3-targeted therapies may represent a novel antiepi-
leptogenic strategy [31]. Indeed, NLRP3 inhibition was
already reported to provide neuroprotection in a kind-
ling model of epilepsy [32].
Epileptogenesis is difficult to study in humans, due
to the heterogeneity of epileptogenic injuries, long
latent periods lasting months to decades, and the
potentially confusing effects of anticonvulsant treat-
ment after the first spontaneous seizure. Animal
models of epilepsy have been crucial in the under-
standing of the physiological and behavioral changes
associated with human epilepsy and they have led to
the discovery of many AEDs [33, 34], but they re-
quire a large number of animals and data collection
is quite slow due to the long latent period until sei-
zures onset [35].
Organotypic hippocampal slice cultures (OHSC),
which are prepared from slices of explanted tissue, rep-
resent a complex multicellular ex vivo environment and
constitute a powerful instrument to elucidate biological
mechanisms [36, 37]. These cultures preserve the
three-dimensional architecture and local environment of
brain cells, including neurons, astrocytes, and microglia,
as well as the neuronal connectivity and the complex
glial-neuronal interactions. Furthermore, cells in organo-
typic brain slices develop and mature similarly to their
in vivo counterparts [38]. Nowadays, these systems are
considered excellent models to study neuroprotection
and they are used as a starting point for drug discovery
[39, 40]. Ex vivo models of epilepsy in hippocampal
slices allow a detailed and well-controlled research of
the mechanisms of epileptogenesis, while still preserving
the network phenotypic features of epilepsy, particularly
the development of spontaneous seizures [41]. Indeed,
spontaneous field potential activity was recorded from
organotypic slices [42, 43]. It was reported that slices
develop epileptiform activity which resembles in vivo
epilepsy, including sensitivity to anticonvulsants and
increasing seizure incidence over time. Detailed
characterization of this system in terms of spontaneous
interictal and ictal-like events allowed to present it as a
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useful model system for investigating the mechanisms of
epileptogenesis, as well as to screen potential antiepilep-
tic drugs [42, 44].
In this study, we aimed to further explore organotypic
slices as a model of epilepsy. We confirmed the occur-
rence of spontaneous epileptiform activity in slices
maintained in Neurobasal/B27 serum-free medium, and
showed the strong incidence of neuroinflammation bio-
markers in these slices, as the enhanced expression and
activation of NLRP3 inflammasome.
We thus demonstrate that organotypic slice cultures
gradually deprived of serum mimic the epileptic-like ac-
tivity, as well as many inflammatory events associated
with in vivo epilepsy. Studies within this system can con-
tribute to a deeper knowledge about the interplay be-
tween epilepsy and inflammation. Furthermore, this
model can be used as a tool to screen potential thera-
peutic candidates for epilepsy.
Methods
Animals
Pregnant female Sprague-Dawley rats were acquired from
Charles River (Barcelona, Spain). The Portuguese law and
European Union guidelines (2010/63/EU) were respected
in all procedures regarding the protection of animals for
scientific purposes. All efforts were made to minimize ani-
mal suffering and to use the minimum number of animals.
This study was approved by the “iMM’s Institutional Ani-
mal Welfare Body–ORBEA-iMM and the National com-
petent authority–DGAV (Direção Geral de Alimentação e
Veterinária).”
Organotypic slice cultures
Organotypic slice cultures were prepared from 6- to
7-day-old Sprague-Dawley rats, according to the inter-
face culture method [45]. After decapitation, brains were
removed and placed in cold Gey’s balanced salt solution
(GBSS, Biological Industries, Kibbutz Beit Haemek,
Israel) with 25 mM D-glucose (Sigma, St. Louis, MO,
USA), under sterile conditions. The hippocampus, to-
gether with the entorhinal cortex (EC) and perirhinal
cortex (PC), (Fig. 1a), was dissected out and sliced trans-
versely at 350 μm using a McIlwain tissue chopper. Five
slices were placed onto porous (0.4 μm) insert mem-
branes (PICM 03050, Millipore, Bedford, MA), which
were transferred to six-well culture trays (Corning Co-
star, Corning, NY). Each well contained 1 ml of culture
medium composed of 50% Opti-MEM, 25% Hanks’
balanced salt solution (HBSS), 25% heat-inactivated
horse serum (HS) (all from Invitrogen, Paisley, UK),
25 mM D-glucose, penicillin (100 units/ml), and
streptomycin (100 μg/ml) (Sigma). Slices were main-
tained at 37 °C with 5% CO2 and 95% atmospheric
air for the following 2 weeks.
Slices were randomly divided in two groups, which
undertook different culture conditions (Fig. 1). Those
designated control slices (CTL, Fig. 1b) were kept in a
serum-based (25% HS) Opti-MEM medium, with
medium renewal twice a week, and did not develop epi-
leptiform activity. Those slices which spontaneously de-
velop epileptiform activity (EL, Fig. 1c) were changed at
3 days in vitro (DIV) to a chemically defined serum-free
based medium, Neurobasal A (Invitrogen), supple-
mented with 2% B27 (Invitrogen), L-glutamine (1 mM)
(Invitrogen), penicillin (100 units/ml), and streptomycin
(100 μg/ml), and decreasing HS concentrations (15%,
10% and 5%), until a serum-free condition was reached
at 9 DIV. In EL slices, medium was renewed every sec-
ond day. Our protocol is different from other reports in
the sense that slices are gradually deprived of serum.
Field potential recordings
Field potential recordings were performed in an
interface-type chamber as previously described by others
[20]. At 14 DIV, slices were transferred to the interface
recording chamber, with a humidified (5% CO2/95% O2)
atmosphere at 36 °C, and with their growth medium
continuously superfused and recirculating at a rate of
2 ml/min. Each slice was visually inspected, ensuring
slice integrity and organization. After an equilibration
period of 20 min, spontaneous field potential recordings
were performed with an extracellular microelectrode
(4 M NaCl, 2–4 MΩ resistance) positioned in the CA3
pyramidal cell layer over 30–40 min. Recordings were
obtained with Axoclamp 2B amplifier, digitized (Axon
Instruments, Foster City, CA), and analyzed by the
Clampex software version 10.2 (Molecular Devices,
Sunnyvale, CA, USA). All recordings were band-pass
filtered (eight-pole Bessel filter at 60 Hz and Gaussian
filter at 600 Hz).
Patch-clamp recordings
Slices were transferred to an Axioskop 2FS upright micro-
scope (Zeiss, Jena, Germany) equipped with a differential
interference contrast-infrared (DIC-IR) CCD video cam-
era (VX44, Till Photonics, Gräfelfing, Germany) and fixed
with a grid in a recording chamber continuously super-
fused by a gravitational superfusion system at 2–3 ml/min
with artificial cerebrospinal fluid (aCSF) containing (in
mM) NaCl 124, KCl 3, NaH2PO4 1.25, NaHCO3 26,
MgCl2 1, CaCl2 2, Glucose 10, pH 7.4 (gassed with 95%
O2, 5% CO2), at room temperature. Patch pipettes (4–
9 MΩ) were pulled from borosilicate glass capillaries
(1.5 mm outer diameter, 0.86 mm inner diameter, Harvard
Apparatus, Holliston, MA, USA) with PC-10 Puller (Nar-
ishige Group, London, UK) and were filled with an in-
ternal solution containing (in mM) K-gluconate 125, KCl
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11, CaCl2 0.1, MgCl2 2, EGTA 1, HEPES 10, MgATP 2,
NaGTP 0.3 and phosphocreatine 10, pH 7.3 adjusted
with KOH (1 M), 280–290 mOsm. Recordings were
performed in current-clamp mode using an EPC-7 elec-
trical amplifier (List Biologic). Signals were low-pass fil-
tered using a 3- and 10-kHz three-pole Bessel filter of
an EPC-7 amplifier, digitized at 10 kHz using a Digidata
1322A board, and registered by the Clampex software
version 10.2 (Molecular Devices). Resting membrane
potential (RMP) was measured immediately after estab-
lishing whole-cell configuration, and action potential
firing was systematically evoked in current-clamp mode
by injecting current pulses of − 50 to + 300 pA, in 10 or
50 pA increments for 1000 ms from an initial holding
potential of − 70 mV. The threshold for action potential
(AP) generation was determined as the difference be-
tween the resting membrane potential and the mem-
brane potential at which phase plot slope reached
10 mV/ms [46].
Western blot analysis
Hippocampi were dissected from five slices and dissoci-
ated by passing 20 times through a 25G needle (Terumo
Europe, Leuven, Belgium) in 150 μL of ristocetin-induced
platelet agglutination buffer (RIPA, 50 mM Tris pH 8.0,
1 mM EDTA (ethykenediamine tetraacetic acid), 150 mM
NaCl, 1% NP40 substitute (Nonyl phenoxlpoylethanol,
Fluka Biochemika, Switzerland), and 10% glycerol), con-
taining a mixture of protease inhibitors (Sigma). Dissoci-
ated tissue was shaken for 15 min at 4 °C. Tissue lysates
were then centrifuged at 13000×g for 10 min to remove
cell debris. The supernatant was collected, and total pro-
tein was quantified using the Bio-Rad DC Protein Assay
Kit (Bio-Rad, Hercules, CA, USA).
Samples (35 μg total protein/well) and protein molecu-
lar weight marker (NZYColour Protein Marker II, NZY-
Tech, Lisbon, Portugal) were boiled at 95 °C for 10 min,
electrophoresed on a 12% SDS-PAGE, and electrotrans-
ferred to PVDF membranes (Merck-Millipore, Feltham,
Fig. 1 Representative photograph of a combined entorhinal cortex-hippocampus slice immediately after dissection. a All slices include the cornu
ammonis (CA), dentate gyrus (DG), entorhinal cortex (EC), and perirhinal cortex (PC). b, c Schematic representation of culture maintenance protocol for
organotypic slices control (CTL) and with spontaneous epileptiform activity (EL). b CTL slices were grown in Opti-MEM-based medium supplemented
with 25% horse serum (HS). Medium renewal, starting at 3 days in vitro (DIV), was performed twice a week. c In EL slices, at 3 DIV, the medium was
changed to Neurobasal A-based medium in the presence of decreasing concentrations of HS (15, 10, and 5%) until complete serum-free medium was
reached at 9 DIV. Medium renewal, starting at 3 DIV, was performed every second day
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UK). Following blocking, membranes were probed with
the primary antibodies and with the appropriate horse-
radish peroxidase (HRP)-conjugated secondary anti-
bodies (1:10000, Santa Cruz Biotechnology, Heidelberg,
Germany) as previously described [47]. Immunoreac-
tions were visualized with ECL Western Blotting Detec-
tion System (GE Healthcare, Buckinghamshire, UK). The
integrated intensity of each band was calculated using
computer-assisted densitometry analysis with ImageJ
software 1.44b. Glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) was used as the loading control.
Images were prepared for printing in Image Lab soft-
ware 5.2.1 (software available in ChemiDoc XRS+
system, Bio-Rad). For each protein evaluated, the chemi-
luminescence image was merged with the colorimetric
image of the molecular weight marker.
The primary antibodies used were mouse monoclonal
antibody anti-αII-spectrin (1:500) and rabbit polyclonal
antibody anti-Caspase-3 (1:1000) from Santa Cruz Bio-
technology; rabbit polyclonal antibody anti-GFAP (1:5000)
from Sigma; and goat polyclonal antibody anti-Iba1
(1:1000), rabbit polyclonal antibody anti-NLRP3 (1:300),
and mouse monoclonal antibody anti-GAPDH (1:5000),
all from Abcam, Cambridge, UK.
Quantitative real-time PCR
Hippocampi were isolated from ten slices, and RNA was
extracted according to QIAGEN RNeasy Mini Kit (QIA-
GEN, Hilden, Germany). The collected tissue was disso-
ciated with a 25G needle in the presence of QIAzol lysis
reagent. RNA concentration was determined using
Nanodrop 1000 (ND-1000 Spectrophotometer, Thermo
Fisher Scientific, Waltham, MA, USA).
In vitro reverse transcription was performed from 2 μg
of total RNA (in 20 μl) and carried out with SuperScript
II Reverse Transcriptase (EC 2.7.7.49, Invitrogen,
Carlsband, CA, USA) in a thermoclycler (MyCycle,
Bio-Rad), according to the manufacturer’s recommenda-
tions (SuperScript First Strand Synthesis Systems for
RT-PCR, Invitrogen). cDNA amplification was carried
out in a Rotor-Gene 6000 real-time rotary analyzer ther-
mocycler (Corbett Life Science, Hilden, Germany) as
former described [47]. Briefly, the reactions took place
in the presence of SYBR Green Master Mix (Applied
Biosystems, Foster City, CA, USA) and 0.2 μM of each
gene-specific primers. RT-qPCR parameters included an
initial denaturation step for 2 min at 94 °C and 50 cycles
with 30 s at 94 °C, 90 s at 60 °C, and 60 s at 72 °C. Reac-
tion specificity was evaluated in all assays by a melting
curve (Additional file 1: Figure S1).
The threshold cycle (Ct) and the melting curves re-
quired for the relative quantification [48] were acquired
with Rotor-Gene 6000 Software 1.7 (Corbett Life Science).
GAPDH was used as the reference internal standard.
The primers used for the proinflammatory cytokines
(see Table 1) were designed using the OligoAnalyzer 3.1,
provided by Integrated DNA Technologies (Coralville,
IA, USA) and acquired to Invitrogen. All mRNA se-
quences from Rattus norvegicus were obtained from the
GenBank sequence database of the National Centre for
Biotechnology Information (http://www.ncbi.nlm.nih.
gov/nucleotide/). Accession numbers are indicated in
Table 1.
Quantification of cell death by propidium iodide uptake
Cell death was assessed by monitoring the cellular up-
take of the fluorescent dye propidium iodide (PI, 3,8-dia-
mino-5-(3-(diethylmethylamino)propyl)-6-phenyl phe-
nanthridinium diiodide, Sigma). PI is a polar compound,
which only enters cells with damaged cell membranes
and interacts with DNA emitting red fluorescence
(630 nm; absorbance 493 nm). It is not toxic to cells and
was proven to be a feasible marker of neuronal cell
death in organotypic slice cultures [49].
PI imaging was carried out at 14 DIV. CTL and EL
slices were incubated with 2 μM sterile PI, diluted in
culture medium for 4 h before imaging. Cellular uptake
of PI was recorded by fluorescence microscopy on a
wide field fluorescence microscope (Axiovert 200, Zeiss,
Germany) using a rhodamine filter. Fluorescence photo-
micrographs were acquired, under identical lighting,
with an EC Plan-NeoFluar 5x objective (Zeiss) with a
numerical aperture of 0.16. For assessment of PI uptake,
the regions of interest (DG, CA1 and CA3) were delin-
eated and the fluorescence intensity was quantified using
the software ImageJ 1.44b (NIH). The intensity value of
each analyzed region was obtained by correction with a
fluorescence background image. PI uptake by each hip-
pocampal region was expressed in arbitrary units of
fluorescence intensity.
Immunohistochemical analysis
Slices were fixed, at 14 DIV, for 1 h with 4% paraformal-
dehyde (PFA, Sigma) diluted in PBS at room
temperature (RT), followed by an incubation in increas-
ing concentrations of a sucrose (Sigma) solution (10 and
20% in PBS) at RT. Slices were kept in a 30% sucrose so-
lution at 4 °C until further use.
Slices were cut out of the insert and put in slides. Each
slice was surrounded with DAKO pen (Dako, Glostrup,
Denmark) to protect staining areas from drying out and
from mixing with each other. Following PBS washes,
slices were incubated for 3 h at RT in blocking solution
containing 10% HS, 10% bovine serum albumin (BSA,
Sigma), and 1% Triton X-100 (Sigma) in PBS, which
ensure simultaneous permeabilization and blocking of
the tissue. Subsequently, slices were incubated with the
primary antibodies for 24 h at 4 °C. Slices were rinsed
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with PBST (PBS containing 0.1% Tween-20), and the
fluorophores coupled-secondary antibodies were applied
to the slices for 4 h at RT. The nuclei were stained with
Hoechst 33342 (20 μg/ml, Invitrogen) for 40 min at RT.
The slices were mounted in Mowiol (Sigma).
For each marker, images were acquired under iden-
tical lighting between conditions, with a frame size of
1024 × 1024 pixels on an inverted confocal laser scan-
ning microscope (Zeiss LSM 710, Zeiss) equipped
with a Plan-Apochromat 20x objective (Zeiss) with a
numerical aperture of 0.80. Hoechst 33342 fluores-
cence was detected with a 405-nm diode laser
(30 mW nominal output). Alexa Fluor 488 fluores-
cence was detected using the 488-nm line of an
Argon laser (25 mW nominal output), and Alexa
Fluor 568 was detected using a 561-nm DPSS laser
(15 mW nominal output). Images were prepared for
printing using Illustrator software from Adobe Sys-
tems (San Jose, CA, USA).
Doublecortin (DCX) fluorescence intensity was quantified
in the DG of CTL and EL slices, using the software ImageJ
1.44b. The final intensity value was obtained by correction
with a fluorescence background image. Fluorescence inten-
sity values are presented as a percentage of CTL slices.
The microglia cell body diameter in CTL and EL slices
stained with Iba1 was measured, using the software Ima-
geJ 1.44b, in 50–70 microglia cells per each hippocampal
area. Whenever the cell body was oval, the cell body
diameter was considered the largest distance passing
through the center of the ellipse.
The primary antibodies used were mouse monoclonal
antibody anti-GFAP (1:1000, Sigma), goat polyclonal
antibody anti-Iba1 (1:1000, Abcam), and mouse
anti-doublecortin (1:500, Santa Cruz Biotechnology). The
secondary antibodies were donkey anti-mouse-Alexa
Fluor 488, donkey anti-goat-Alexa Fluor 488, and donkey
anti-mouse-Alexa Fluor 568 (1:500, Invitrogen).
ELISA
Hippocampi were dissected from five slices and homoge-
nized, as for western blot, in ice-cold RIPA buffer con-
taining a mixture of protease inhibitors (Sigma). The
lysates were centrifuged, and the supernatants, contain-
ing the cytosolic and membrane fraction, were collected
to measure IL-1β, TNF-α, and IL-6 in the tissue. Total
protein was quantified using the Bio-Rad DC Protein
Assay Kit (Bio-Rad). IL-1β, TNF-α, and IL-6 protein
levels were quantified by ELISA, according to the manu-
facturers’ suggested protocol (R&D Systems, Abingdon,
UK), using selective antibodies. Absorbance was read at
405 nm. The detection limit was < 3 pg/ml.
Statistical analysis
All statistical analysis was performed using GraphPad
Prism software (San Diego, CA, USA). Most compari-
sons between CTL and EL slices were made using an
unpaired t test. Regarding PI uptake experiments and
microglia cell body diameter measurements, statistical
analysis was performed with one-way ANOVA, followed
by Bonferroni’s comparison test. The number of inde-
pendent cultures or cells (n) used in each assay is indi-
cated in the legend of each figure. In all figures, data are
presented as mean ± SEM. Values of p < 0.05 were con-
sidered to account for statistically significant differences.
Results
Slices maintained in Neurobasal A-serum-free medium
exhibit interictal-like activity
As depicted in Fig. 1a, the organotypic slices used
throughout this work contain the hippocampal complex,
namely the dentate gyrus (DG) and the cornu ammonis
areas (CA1 and CA3) of the hippocampus, as well as the
entorhinal (EC) and perirhinal (PC) cortex. Indeed, clinical
research and animal models of epilepsy have suggested
Table 1 Primers used for the analysis of proinflammatory cytokines by RT-PCR. All primers were designed using the OligoAnalyzer
3.1, provided by Integrated DNA Technologies
Gene Acession number Primer sequence (5′–3′) PCR fragment size (bp)
Proinflammatory cytokines
IL-1β NM_031512.2 Forward: TCCTCTGTGACTCGTGGGAT 309
Reverse: GTTTGGGATCCACACTCTCCA
TNF-α NM_012675.3 Forward: ATGGGCTCCCTCTCATCAGT 106
Reverse: GCTTGGTGGTTTGCTACGAC
IL-6 NM_012589.2 Forward: GCAAGAGACTTCCAGCCAGT 203
Reverse: TTGCCATTGCACAACTCTTTTCT
Housekeeping gene
GAPDH NM_017008 Forward: GTTTGTGATGGGTGTGAACC 170
Reverse: TCTTCTGAGTGGCAGTGATG
The table indicates the gene, the gene accession number, the primer sequence, and the PCR fragment size
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that these cortical areas play an important role in seizure
generation [50].
Spontaneous activity of the slices was assessed at 14
DIV. CTL and EL slices were transferred to the interface
chamber, and field potentials were recorded (40 min)
under a constant superfusion with growth medium.
Figure 2 shows representative field potential recordings
of spontaneous activity obtained in CA3 area of CTL
(Fig. 2a–CTL) and EL (Fig. 2a–EL) organotypic slices at
14 DIV. CTL slices depict a spontaneous typical physio-
logical activity, while EL slices exhibit spontaneous
interictal-like discharges, which resemble in vivo epi-
lepsy, in accordance with what was previously described
by others [42].
CTL and EL slices have identical resting membrane
potential and firing threshold
To evaluate the resting membrane potential of neurons,
CTL and EL slices were transferred to the chamber of
an upright microscope and RMP values of CA3 pyram-
idal cells were measured immediately upon establishing
whole-cell configuration. We found no statistically sig-
nificant differences between RMP measured in neurons
from CTL slices when compared with neurons from EL
slices (CTL − 62.57 ± 1.59 mV and EL − 59.25 ± 1.89 mV,
p > 0.05, t test) (Fig. 2b).
Action potentials were then evoked under
current-clamp mode by injecting current pulses (− 50 to
+ 300 pA, in 10 or 50 pA increments for 1000 ms) from
an initial holding potential of − 70 mV. The threshold
for AP generation was measured as the beginning of the
upward rise of the AP when dV/dT exceeded 10 mV/ms.
The delta between the RMP of each neuron and the
threshold potential (Vt), dRMP-Vt, at which they first
fired an AP was not significantly different (p > 0.05, t
test) between CTL (dRMP-Vt 21.63 ± 1.63 mV) and EL
(dRMP-Vt 21.40 ± 1.81 mV) slices (Fig. 2c, d).
EL slices have increased doublecortin immunoreactivity
Over the last decade, changes in hippocampal neurogen-
esis have emerged as a hallmark of temporal lobe epi-
lepsy (TLE) [14].
Fig. 2 Electrophysiological properties of organotypic slices control (CTL) and with spontaneous epileptiform activity (EL). a Representative field
potential recordings of spontaneous activity from CA3 area of CTL and EL organotypic slices. CTL slices depict a regular physiological activity,
while EL slices exhibit epileptiform activity at 14 DIV. All vertical bars, 1 mV. b Resting membrane potential (RMP) of CA3 pyramidal neurons were
measured immediately upon establishing whole-cell configuration and did not significantly differ between CTL and EL slices. c There were also
no statistically significant changes between the action potential (AP) threshold measured from neurons in CTL and EL slices. d Representative
tracings for each condition are shown. Data represent the mean ± SEM. n = 7–9 cells per condition, from 3 to 4 independent cultures, unpaired
t test
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Doublecortin (DCX) is a microtubule-associated
phosphoprotein, which is widely used as a marker for
immature neurons derived from newly generated neural
precursor cells and has been validated to assess changes
in the level of neurogenesis [11].
Thus, an immunofluorescence protocol was performed
to evaluate the DCX staining in the DG of CTL and EL
slices at 14 DIV.
As can be observed in Additional file 2: Figure S2,
DCX staining was increased in slices that display epilep-
tiform activity. Indeed, DCX fluorescence intensity was
found to be significantly higher (*p < 0.05, t test) in the
DG of EL slices, thus suggesting increased neurogenesis.
EL slices show higher αII-spectrin cleavage
Neuronal death is considered an important feature of
epilepsy. To evaluate if neuronal death was increased in
EL slices, we quantified αII-spectrin cleavage and
caspase-3 activation by a western blot assay, carried out
with protein extracts obtained from the hippocampal re-
gion of the slices. Calpain-mediated degradation of
αII-spectrin results in the formation of two unique and
highly stable SBDPs with a molecular weight of 145 and
150 kDa (SBDP145 and SBDP150), which can be further
cleaved by caspase-3 yielding shorter fragments. The
presence of the calpain-cleaved fragments is usually
indicative of necrotic and excitotoxic neuronal death.
On the other hand, caspase-3-mediated αII-spectrin
cleavage leads to the formation of a fragment with
150 kDa (SBDP150), which is further degraded by
caspase-3, producing the apoptotic-specific SBDP120,
with 120 kDa [51].
Thus, an antibody which recognizes the full length
αII-spectrin, as well as the calpain- and caspase-3-signature
SBDPs, was used. As can be observed in Fig. 3a, this anti-
body identified two bands: a high molecular weight band,
which corresponds to full length αII-spectrin (250 kDa),
and a lower one for SBDPs. The expression of SBDP145
and SBDP150 was not possible to visualize separately
(Fig. 3a). However, the apoptotic-specific SBDP120, which
results from the caspase-3 cleavage of αII-spectrin, was ab-
sent from both conditions, indicating that the lower band
recognized by αII-spectrin antibody corresponds exclusively
to the calpain-signature SBDPs.
CTL and EL slices have a similar expression of full
length αII-spectrin (Fig. 3c, p > 0.05, t test). The results
also indicate that the ratio SBDP145/150 to αII-spectrin
was significantly increased (Fig. 3d, *p < 0.05, t test) in
EL slices, pointing to a higher αII-spectrin cleavage by
calpain in these slices. Furthermore, the band for active
caspase-3 (17 kDa) is absent from the immunoblot
(Fig. 3b) and no differences are found in pro-caspase 3
expression (Fig. 3e, p > 0.05, t test). These results corrob-
orate the sole detection of SBDP145/150 originated by
calpain-mediated cleavage of αII-spectrin and point to
an increased necrosis in EL slices.
EL slices show increased PI uptake
To evaluate neuronal death across the different regions
of the hippocampus, the PI uptake assay was carried out
in CTL and EL slices at 14 DIV.
The representative fluorescence photomicrographs of
both groups of slices (Fig. 4a) suggested that PI incorp-
oration was increased in EL slices. This observation was
corroborated by the quantification of PI uptake in each
hippocampal region, expressed in arbitrary units of
fluorescence intensity (Fig. 4b). PI uptake in granular
and pyramidal neurons of EL slices was significantly
higher (*p < 0.05, one-way ANOVA) than that detected
in the same regions of CTL slices. Also, in both groups
of slices, CA1 pyramidal neurons show a significantly
higher PI uptake than granular neurons (#p < 0.05,
one-way ANOVA). Specifically, for DG, CTL 86.71 ±
8.016 vs EL 121.3 ± 10.51; for CA3, CTL 105.4 ± 6.920 vs
EL 135.5 ± 9.846; and for CA1, CTL 130.1 ± 10.67 vs EL
169.8 ± 11.83.
EL slices depict increased gliosis
Activation of astrocytes and microglia are considered
a molecular hallmark of epilepsy, and recent findings
point to a role of glial cells in the pathogenesis of
this disorder [52, 53].
To investigate if gliosis was associated with epilepti-
form activity, two experimental approaches were used: a
western blot assay to evaluate the overall expression of
GFAP and Iba1 and an immunohistochemistry assay to
evaluate morphological changes in astrocytes and
microglia.
The western blot was carried out with 14 DIV hippo-
campal lysates obtained from CTL and EL slices. The
immunoblots (Fig. 5a, c) showed an increased expression
of GFAP and Iba1 in EL slices. Indeed, the densitometry
analysis (Fig. 5b) attested a significant increase in GFAP
expression in EL slices (*p < 0.05, t test). Likewise, the
increased Iba1 expression in EL slices, evident in the im-
munoblot (Fig. 5c), was supported by the densitometry
analysis (Fig. 5d), which indicated that Iba1 expression
was significantly higher (***p < 0.001, t test) in EL slices,
when compared to CTL ones.
An immunofluorescence analysis was also performed
in CTL and EL slices to assess the morphological fea-
tures of astrocytes (Fig. 6) and microglia (Fig. 7) in the
main hippocampal areas. At 14 DIV, slices were fixed
with PFA and handled as described before.
In the DG and CA regions of CTL slices (Fig. 6a–A1, A2,
A3), most GFAP-positive astrocytes have thin processes
and display preservation of individual domains, which can
be observed in the magnified panels, Fig. 6a–A1a, A2a, and
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A3a. However, some hypertrophic cell bodies can also
be observed suggestive of a mildly activated state.
This basal astrogliosis in organotypic slices has long
been reported by others [54]. However, in EL slices
(Fig. 6b), a moderate/reactive astrogliosis can be no-
ticed in all regions of the hippocampus, which include
the presence of tick and highly superimposed astro-
cytic processes, resulting in the disruption of individ-
ual domains. These features are visible in the
magnified panels, Fig. 6b–B1a, B2a, and B3a.
Figure 7 shows the occurrence of microglia cells, iden-
tified by Iba1 expression, in all hippocampal regions of
CTL and EL slices. In CTL slices (Fig. 7a), most micro-
glia have a ramified morphology, characteristic of a rest-
ing state, as can be noticed in Fig. 7a–A1a, A2a, and
A3a. In EL slices (Fig. 7b), microglia are more abundant
in all regions of the hippocampus, which agrees with the
western blot results described above. Furthermore, most
microglia have larger cell bodies and have changed their
morphology from ramified to bushy-like cells with fewer
processes, as observable in Fig. 7b–B1a, B2a, and B3a. In
comparison with CTL slices, microglia in EL slices have
a significantly increased cell body diameter in all regions
of the hippocampus (***p < 0.001, one-way ANOVA), as
attested by the quantification depicted in Fig. 7c. Within
each condition, no statistical difference was found be-
tween hippocampal areas (p > 0.05, one-way ANOVA).
The mean microglia cell body diameter for CTL slices
(DG 11.6 μm± 0.32; CA3 11.9 μm± 0.30; CA1 11.5 μm
± 0.31) is higher than 7.5 μm reported by others [55] in
resting microglia. This points to a mixed population of
resting and reactive microglia in CTL slices, which is in
accordance with some basal microglia activation known
to occur in organotypic slices [54]. However, in EL slices,
the mean microglia cell body diameter increases ap-
proximately twofold in relation to CTL ones (DG
18.9 μm± 0.82; CA3 17.6 μm± 0.64; CA1 19.8 μm±
0.63), supporting the qualitative morphological analysis.
Thus, the described morphological alterations depicted
by astrocytes and microglia corroborate an increased
astrogliosis and microgliosis in EL slices.
Expression of proinflammatory cytokines is increased in
EL slices
Recently, inflammatory-related events have been in-
tensely discussed in the context of epilepsy and were
Fig. 3 Western blot analysis of αII-spectrin cleavage and Pro-caspase 3 of organotypic slices control (CTL) and with spontaneous epileptiform
activity (EL). a, b Representative immunoblots of αII-spectrin (250 kDa), SBDP 145/150 (145/150 kDa), Pro-caspase 3 (32 kDa), and GAPDH (37 kDa).
c–e Densitometry analysis was performed with ImageJ software using GAPDH as internal control. c Full length αII-spectrin expression was similar
between CTL and EL slices, while d the ratio SBDP 145/150 to αII-Spectrin was significantly upregulated in EL slices. e No differences were found
in Pro-caspase 3 expression between CTL and EL slices. All values are mean ± SEM. n = 4, *p < 0.05, unpaired t test
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proposed as potential therapeutic targets for new antiep-
ileptic drugs [56, 57].
After showing the occurrence of gliosis in EL slices, it
was pertinent to evaluate alterations in the expression of
proinflammatory cytokines, namely IL-1β, TNF-α, and
IL-6, which are expressed at very low levels in the nor-
mal brain, but undergo a fast increase in expression after
the induction of seizures [58, 59].
Thus, the expression of these proinflammatory cyto-
kines was evaluated at the mRNA and protein level in
CTL and EL slices at 14 DIV.
The transcript expression was evaluated by RT-qPCR,
and the results are depicted in Fig. 8a. As can be ob-
served, the mRNA expression of IL-1β, TNF-α, and IL-6
is significantly upregulated in EL slices (*p < 0.05, t test).
The protein concentration of these cytokines in the
tissue, Fig. 8b, was calculated by an ELISA assay. At the
time point evaluated, protein levels of IL-1β and IL-6
were found to be increased in EL slices (*p < 0.05, t test),
but TNF-α change at the protein level did not reach
statistical significance (p > 0.05, t test).
NLRP3 expression is increased in EL slices
Recently, studies indicate a correlation between en-
hanced NLRP3 inflammasome expression and several
neurological-related disorders [30]. NLRP3 activation
leads to the processing of pro-IL-1β and pro-IL-18 by
caspase-1, with the consequent increased production of
the mature cytokines. Since IL-1β was upregulated in EL
slices, it was relevant to evaluate if NLRP3 expression
was altered in these slices.
To evaluate the differential expression of NLRP3
inflammasome between CTL and EL slices, a western
blot was carried out with 14 DIV hippocampal lysates.
Fig. 4 Propidium iodide uptake of organotypic slices control (CTL) and with spontaneous epileptiform activity (EL). a Representative fluorescence
photomicrographs of PI uptake in CTL and EL slices. b Quantification of PI uptake by each hippocampal region, expressed in arbitrary units of
fluorescence intensity, was performed with ImageJ software. In both conditions, the highest PI uptake was observed in CA1 pyramidal region.
However, EL slices have a higher PI incorporation in all hippocampal areas when compared to CTL ones. All values are mean ± SEM. n = 17–29
slices per condition, from 3 to 4 independent cultures. Statistical tests were performed with one-way ANOVA, followed by Bonferroni’s comparison
test, *p < 0.05, for comparisons within the same hippocampal area, #p < 0.05, for comparisons within the same group, as depicted by the lines above
the bars. Scale bar, 200 μm
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The immunoblot (Fig. 9a) shows that NLRP3 expression
was increased in EL slices. This result was confirmed by
the densitometric analysis (Fig. 9b), which indicated a
statistical significant increase (*p < 0.05, t test) in NLRP3
expression in EL slices.
Discussion
This work compares “healthy” organotypic slices with
those displaying epileptiform activity, in terms of inflam-
matory features. We herein show that slices, which ex-
hibit spontaneous epileptiform activity resembling in
vivo epilepsy, also depict inflammatory features found in
animal models of epilepsy and in TLE patients. We de-
scribe increased neuronal death, activation of astrocytes
and microglia, and enhanced expression of proinflamma-
tory cytokines, namely IL-1β, TNF-α, and IL-6. We also
show that NLRP3 inflammasome expression is increased
in slices depicting spontaneous activity. By recapitulating
key inflammatory features of epilepsy, the proposed sys-
tem is of value for mechanistic studies of this disease
and can be used as a tool for evaluating potential thera-
peutic approaches.
Our work confirms the development of interictal-like
spikes in combined entorhinal-hippocampus organotypic
slices. It was already reported that epileptiform activity
developed in organotypic slices later than 7 DIV, with
primarily interictal-like spikes and bursts of activity at
14 to 17 DIV which preceded ictal-like discharges after
21 DIV [42]. These authors suggested that the
reorganization of the local network caused by deafferen-
tation and deefferentation occurring during tissue slicing
could be the cause of spontaneous activity in organoty-
pic hippocampal slice cultures. However, as we now
demonstrate, slices maintained in a serum containing
medium, herein denominated CTL slices, do not display
spontaneous activity, precluding the possibility that slice
preparation per se could be the only cause for spontan-
eous activity. In our work, CTL slices only depicted a
regular activity (Fig. 2a–CTL), whereas slices progres-
sively depleted of serum in the growth medium revealed
interictal-like events (Fig. 2a–EL). Interictal spikes in
electroencephalographic recordings from epilepsy pa-
tients are brief paroxysmal discharges observed between
spontaneous recurrent seizures and have been regarded
as markers for ongoing epileptogenesis [60]. Hence, ac-
cording to our recordings, slices gradually deprived of
serum in the growth medium mimic some aspects of
epileptogenesis, while slices maintained in serum-based
conditions do not. To our knowledge, such assessment
was never carried out.
Fig. 5 Western blot analysis of GFAP and Iba1 in organotypic slices control (CTL) and with spontaneous epileptiform activity (EL) at 14 DIV. a, c
Representative immunoblots for GFAP (50 kDa), Iba1 (17 kDa), and GAPDH (37 kDa). b, d Densitometry analysis was performed with ImageJ
software using GAPDH as internal control. GFAP and Iba1 expression are significantly upregulated in EL slices. All values are mean ± SEM. n = 4,
*p < 0.05, ***p < 0.001, unpaired t test
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Serum-free and serum-replacement medium formu-
lations have become essential for biotechnology in-
dustries. The elimination of animal components aims
standardization, consistency, and reduced risks of
contamination in cell culture processes. Furthermore,
serum-free medium mimics the serum-free environ-
ment found in CNS parenchyma.
However, serum withdrawal from the maintenance
medium may play a role in excitability since it affects
hippocampal circuitry. It was reported that dendritic
spine density and morphology in organotypic slices
depend on the presence of serum in the culture
media [61] and granule layer cell density was also de-
creased in the absence of serum [62]. It is therefore
plausible to foresee that serum deprivation leads to
persistent changes in the hippocampal circuitry that
ultimately decrease the threshold for spikes. Further-
more, recent evidences have shown that serum
deprivation increases reactive oxygen species (ROS)
production [63]. Although ROS are removed by the
antioxidant systems to maintain redox homeostasis,
situations of excessive ROS production occur and
have been implicated in many pathological disorders
including cancer, aging, and neurological diseases
[64]. Indeed, ROS generation was suggested to be one
of the critical elements for NLRP3 activation [65, 66],
one of the features that we observe in our system.
Yet, the detailed mechanism through which serum
deprivation contributes to epileptiform activity in
organotypic slices was not matter of this work and is
Fig. 6 Representative morphology of astrocytes in organotypic slices control (CTL) and with spontaneous epileptiform activity (EL) at 14 DIV.
Images of GFAP-stained astrocytes (green) and Hoechst-stained nuclei (blue) were acquired on a confocal laser microscope (Zeiss LSM 710) with
a 20x objective. Magnified images of the dashed areas are shown. a In CTL slices, most astrocytes show thin processes with preservation of
singular domains. b In EL slices, astrocytes have hypertrophic cell bodies, with extensive overlap of astrocytic processes and disruption of individual
domains. Scale bars, 50 μm
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difficult to address due to the lack of detailed know-
ledge of the serum and culture media composition.
The hippocampus has become one of the most exten-
sively studied area of the mammalian brain and is con-
sidered the most vulnerable brain region for damage.
Indeed, its impaired function has been reported in many
human brain diseases, such as hypoxia, ischemia, and
epilepsy [36].
An association between neuronal death and epilepto-
genesis has been intensely debated [4]. This work
assessed cell death by necrosis and apoptosis, using
αII-spectrin cleavage, a major substrate of calpains and
Fig. 7 Representative morphology of microglia in organotypic slices control (CTL) and with spontaneous epileptiform activity (EL) at 14 DIV.
Images of Iba1-stained microglia (green) and Hoechst-stained nuclei (blue) were acquired on a confocal laser microscope (Zeiss LSM 710) with a
20x objective. Magnified images of the dashed areas are shown. a Most microglia in CTL slices have a ramified morphology, characteristic of a
resting state. b EL slices depict microglia with a large cell body and retracted processes, corroborating an activated “bushy-like” state. c The
diameter of microglia cell body was quantified with ImageJ software. In EL slices, microglia show a significant increase in cell body diameter in
all hippocampal areas. All values are mean ± SEM. n = 50–70 microglia cells per hippocampal area per condition, from 3 independent
cultures, ***p < 0.001, one-way ANOVA, followed by Bonferroni’s comparison test. Scale bars, 50 μm
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caspases, for that purpose. The calpain-mediated frag-
ments of αII-spectrin cleavage (SBDP145/150) were
found in slices with epileptiform activity (Fig. 3a), while
the caspase-3-mediated apoptotic-specific fragment
(SBDP120) was not. This result points to the occurrence
of necrosis, which is associated with massive Na+ and
Ca2+ influxes and thus with excitotoxicity. Nevertheless,
a cross-talk between apoptosis and necrosis cascades
[67], as well as caspase-independent cell death processes
[68], is gaining recognition among the scientific commu-
nity and cannot be discarded. Moreover, novel mecha-
nisms of cell death [69, 70], beyond the traditional
concepts of necrosis and apoptosis, including autophagy,
phagoptosis, necroptosis, and pyroptosis, are nowadays
Fig. 8 Expression of proinflammatory cytokines in organotypic slices control (CTL) and with spontaneous epileptiform activity (EL) at 14 DIV. a RT-
qPCR analysis of IL-1β, TNF-α, and IL-6 shows a transcript upregulation for all cytokines in EL slices. b IL-1β and IL-6 protein concentration in
tissue, assessed by ELISA, is also significantly increased in EL slices. All values are mean ± SEM. n = 3–4, *p < 0.05, unpaired t test
Fig. 9 Protein levels of NLRP3 in organotypic slices control (CTL) and with spontaneous epileptiform activity (EL) at 14 DIV. a Representative
immunoblot for NLRP3 (118 kDa) and GAPDH (37 kDa). b Densitometry analysis was performed with ImageJ software using GAPDH as internal
control. NLRP3 expression is significantly upregulated in EL slices. All values are mean ± SEM. n = 4, **p < 0.01, unpaired t test
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being considered to have a role in epileptogenesis [71].
Indeed, the increased NLRP3 expression and activation
observed in slices with epileptiform activity point to pyr-
optosis as one of those mechanisms. But only a complete
evaluation of cell death throughout time in culture will
fully clarify the cell death mechanisms relevant in this
system.
Region-specific neuronal death, across the different re-
gions of the hippocampus, was also explored by the PI
uptake assay. PI is a nucleic acid dye that is excluded
from viable cells, but can enter in dying or dead cells
with compromised membranes and stain their nuclei
[49]. We found some PI incorporation in all slices, re-
gardless of culture condition, reflecting cell death as a
consequence of the massive deafferentation and deeffer-
entation which occurs during tissue slicing. Truly, al-
though after a few DIV the development of synapses in
organotypic slices matches synaptogenesis in vivo, it is
known that the density of synaptic contacts decreases
immediately after explantation [72]. Nevertheless, at 14
DIV, slices with epileptiform activity display a stronger
incidence of PI uptake, and thus cell loss, than control
slices (Fig. 4). Stronger PI staining was largely confined
to the main neuronal cell layers of the hippocampus,
such as DG granular layer and CA1 and CA3 pyramidal
layers, suggesting that the dying cells were neurons and
thus corroborating neuronal loss, as concluded by the
results obtained from αII-spectrin cleavage.
An increased neurogenesis was found in the DG of the
slices which display epileptiform activity, corroborating
what is reported in many animal models of epilepsy [14].
However, the impact of the newly born granule cells in
the progression of the epileptiform activity was not ad-
dressed in this study.
Alterations in glial cells near or at the site of a lesion,
named as gliosis, constitute a pathological hallmark of
damaged CNS tissue, but the way in which gliosis influ-
ences a specific neuropathological condition is deter-
mined by many factors, including type of disease, injury
severity, time after insult, damage location, and cellular
changes [53].
Many cellular and molecular processes have been as-
sociated with epileptogenesis. Neuroinflammation, which
includes the synthesis/release of proinflammatory medi-
ators by activated astrocytes and microglia is one of
them. In fact, inflammatory events have been extensively
discussed in the context of epilepsy and have been pro-
posed as having a role in the pathophysiology of this
neurological disorder [73, 74]. Nowadays, brain inflam-
mation is pointed out as a potential biomarker in epi-
lepsy [75]. In our system, slices with epileptiform activity
show noticeable signs of inflammation when compared
to control slices, specifically activation of astrocytes and
microglia, increased expression of proinflammatory
cytokines, namely IL-1β, and NLRP3 overexpression and
activation.
Our results clearly point to the loss of individual do-
mains and extensive overlap of astrocytic processes in
slices with epileptiform activity (Fig. 6). It is important
to point out that the understanding about the functions
and effects of reactive astrogliosis, and their impact on
neural function, are still at an early stage. Nowadays, re-
searchers still have a prevalent negative view of reactive
astrogliosis and ultimately of glial scar formation, but
new lines of evidence point towards its beneficial func-
tions, particularly concerning neural protection and re-
pair, and regulation of CNS inflammation [20]. In this
paradoxical view, reactive astrocytes act not only to acti-
vate inflammation, at early times after insults, but also
to form cell migration barriers that delineate areas of in-
tense inflammation, thereby restricting the spread of in-
flammatory cells into nearby healthy tissue [76].
Together with reactive astrogliosis, increased microglia
proliferation and microglia morphological changes were
also observed in slices with epileptiform activity (Fig. 7).
In contrast to the resting microglia state observed in
control slices, microglia exhibit an activated “bushy-like”
appearance in slices with epileptiform activity. We antic-
ipated the occurrence of some amoeboid fully functional
phagocytic microglial cell to clear up the cellular debris
derived from neuronal death, but amoeboid microglia
was not detected at the time point under evaluation.
Interestingly, this work has shown that slices with epi-
leptiform activity demonstrated an increased mRNA ex-
pression of proinflammatory cytokines, namely IL-1β,
TNF-α, and IL-6 (Fig. 8). Indeed, these cytokines exhibit
a low expression level in healthy brain, but their messen-
ger RNA (mRNA) and protein levels were reported to be
rapidly increased after the induction of seizures [59]. At
the protein level, only IL-1β and IL-6 show an in-
crease in EL slices. TNF-α protein levels remain un-
changed between CTL and EL slices, which can be
attributed to regulatory processes occurring after
TNF-α mRNA production [77] or to the time point
under evaluation. In face of the gliosis herein de-
tected, we anticipate that reactive astrocytes and acti-
vated microglia are the major contributors for the
increased expression of proinflammatory cytokines, as
described by others [58, 78].
Furthermore, NLRP3 overexpression in slices with
epileptiform activity, together with the increased produc-
tion of IL-1β, points to a role for NLRP3 inflammasome
signaling in epileptogenesis and corroborates that NLRP3
may represent a potential therapeutic target for the treat-
ment of epilepsy, as suggested [31]. Indeed, NLRP3 is
nowadays considered a promising therapeutic target for
the treatment of neuroinflammation-associated neuro-
logical diseases [79].
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It is worthwhile to notice that organotypic slice cul-
tures have become a powerful tool to study physiological
and pharmacological properties of tissues, since they re-
produce the in vivo environment, maintaining the cyto-
architecture of the original tissue. Also, they are
relatively inexpensive, markedly reduce the number of
animals, and are easy to prepare with no requirements
for lengthy animal surgery nor arduous monitorization
of physiological parameters, complying with the 3Rs (re-
duce, refine, replace). In OHSC, the effects of com-
pounds and drugs can be examined without concern
about their ability to pass through the BBB and most
molecular biology techniques can be applied. However,
some drawbacks are still pointed to these types of cul-
tures, namely RNA/protein extraction from few slices,
cell morphology assessment with 5–7 cell layers, and the
variability in PI staining.
Organotypic slice cultures are established in the study of
brain disorders [80]. The most explored brain area in
organotypic slice cultures is the hippocampus. Hippocam-
pal organotypic slice cultures are considered adequate to
explore the basic mechanisms of epileptogenesis [40, 41],
to study stroke and trauma brain injury [81], to study
beta-amyloid toxicity, as a model for Alzheimer’s disease,
and other neurodegenerative diseases [40], and are
described to be suitable for neuroprotection studies [39].
Ventral mesencephalon and striatum, as well as
cortex-corpus callosum-striatum-SN, organotypic slices,
were explored to study Parkinson’s disease [80, 82], and
organotypic cerebellar slice cultures, which mimic many
aspects of axon myelination and cerebellar functions, ap-
pear to be the best alternative to in vivo experiments and
the most commonly used model for investigating novel
therapeutic strategies in multiple sclerosis [83]. It was also
reported that organotypic brain slices are an excellent tool
to address the therapeutic potential of stem cells, since
they allow to study the effect of cell grafts, alone or com-
bined with biomaterials, and to assess the responses of
endogenous and implanted cells, as well as their inter-
action [82]. Nevertheless, although organotypic slice cul-
tures are considered an excellent screening tool, they
cannot replace in vivo models, which remain indispens-
able to evaluate the functional outcome of any therapeutic
strategy.
The system herein described, which uses entorhinal
cortex-hippocampus organotypic slices, opens a new
window to explore neuroinflammation as a cause/conse-
quence of epileptogenesis and reinforces the value of
organotypic brain slice cultures as a platform to study
brain function.
Conclusions
In conclusion, this system is an excellent tool for moni-
toring epileptogenesis and the dynamics of spontaneous
activity. It also mimics the inflammatory events associ-
ated with in vivo epilepsy and allows to interfere
pharmacologically with inflammatory pathways, such as
the NLRP3 inflammasome signaling, before and after the
onset of epileptic-like events, prompting the screening
of potential targets for antiepileptic drugs.
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Additional file 1: Figure S1. Melting curves obtained by RT-qPCR of
IL-1β, TNF-α, IL-6 and GAPDH transcripts. Y axis represents the first
derivate of raw fluorescence and X axis corresponds to temperature. Each
curve has a single melting peak, which indicates that a single PCR
product is being amplified. (TIF 46 kb)
Additional file 2: Figure S2. Neuronal differentiation in the DG of
organotypic slices control (CTL) and with spontaneous epileptiform
activity (EL) at 14 DIV. a Images of Doublecortin (DCX) stained immature
neurons (red) and Hoechst stained nuclei (blue) were acquired on a
confocal laser microscope (Zeiss LSM 710) with a 20x objective. b
Doublecortin fluorescence intensity, quantified with ImageJ software, is
significantly higher in EL slices. All values are mean ± SEM. n = 8 slices per
condition, from 3 independent cultures, *p < 0.05, unpaired t-test. Scale
bars, 50 μm. (TIF 352 kb)
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